Patient Panel Statistics 2026: Patient Profiles by Country, Therapeutic Area and Condition
These statistics describe the Global Vox Populi patient panel: people living with diagnosed conditions who take part in health research, across 731 conditions in 27 therapeutic areas and 193 countries.
Where the patient panel is
Panel size by country. Hover for figures, click a country to see its breakdown.
Key statistics
- The Global Vox Populi patient panel has 71,411,997 patient profiles in 193 countries (October 2026).
- China has the most (2,403,697, 3.4% of the total), followed by Japan, the United States, India and Italy. Together the top five countries hold 12.1%.
- By region, Sub-Saharan Africa is the largest (17.5%), followed by Latin America & Caribbean (15.1%) and Western Europe (13.7%).
- The median country panel has 298,954 patient profiles; 193 countries have 10,000 or more.
- By therapeutic area, the largest group is Aesthetics & Cosmetic (33.3%), then Cardiovascular (6.9%).
- The conditions with the most profiles are Dental caries (1.1M), Tooth discoloration / whitening (941K), Patent foramen ovale (939K), Tension-type headache (935K), Helicobacter pylori infection (885K).
Countries with the most patient profiles
Top 20 countries
Panel sizeBy region
| Region | Patient profiles | Share | Countries |
|---|---|---|---|
| Sub-Saharan Africa | 12,485,710 | 17.5% | 49 |
| Latin America & Caribbean | 10,788,411 | 15.1% | 33 |
| Western Europe | 9,815,356 | 13.7% | 24 |
| Central & Eastern Europe | 8,620,561 | 12.1% | 23 |
| Middle East & North Africa | 8,214,914 | 11.5% | 20 |
| East Asia | 5,757,506 | 8.1% | 4 |
| Southeast Asia | 5,091,192 | 7.1% | 11 |
| South Asia | 4,059,314 | 5.7% | 8 |
| North America | 2,589,213 | 3.6% | 2 |
| Central Asia | 2,139,944 | 3.0% | 5 |
| Oceania | 1,849,876 | 2.6% | 14 |
Breakdown of the patient panel
Therapeutic area
All countriesCompare countries
Pick up to five countries to compare their patient panel side by side.
Patients by country: full table
| Rank | Country | Region | Patient profiles | Share | |
|---|---|---|---|---|---|
| 1 | China | East Asia | 2,403,697 | 3.37% | |
| 2 | Japan | East Asia | 1,974,800 | 2.77% | |
| 3 | United States | North America | 1,544,052 | 2.16% | |
| 4 | India | South Asia | 1,354,449 | 1.90% | |
| 5 | Italy | Western Europe | 1,339,541 | 1.88% | |
| 6 | Russia | Central & Eastern Europe | 1,284,147 | 1.80% | |
| 7 | South Korea | East Asia | 1,150,843 | 1.61% | |
| 8 | Spain | Western Europe | 1,139,370 | 1.60% | |
| 9 | Indonesia | Southeast Asia | 1,063,232 | 1.49% | |
| 10 | Brazil | Latin America & Caribbean | 1,054,165 | 1.48% | |
| 11 | Canada | North America | 1,045,161 | 1.46% | |
| 12 | Colombia | Latin America & Caribbean | 1,010,196 | 1.41% | |
| 13 | Poland | Central & Eastern Europe | 1,005,227 | 1.41% | |
| 14 | Argentina | Latin America & Caribbean | 899,284 | 1.26% | |
| 15 | Saudi Arabia | Middle East & North Africa | 868,823 | 1.22% | |
| 16 | Australia | Oceania | 772,736 | 1.08% | |
| 17 | Kenya | Sub-Saharan Africa | 747,004 | 1.05% | |
| 18 | Malaysia | Southeast Asia | 739,918 | 1.04% | |
| 19 | Nigeria | Sub-Saharan Africa | 737,267 | 1.03% | |
| 20 | Mexico | Latin America & Caribbean | 706,675 | 0.99% | |
| 21 | Chile | Latin America & Caribbean | 694,646 | 0.97% | |
| 22 | Bangladesh | South Asia | 677,603 | 0.95% | |
| 23 | Germany | Western Europe | 669,787 | 0.94% | |
| 24 | Morocco | Middle East & North Africa | 666,970 | 0.93% | |
| 25 | United Kingdom | Western Europe | 666,387 | 0.93% | |
| 26 | Ukraine | Central & Eastern Europe | 651,636 | 0.91% | |
| 27 | France | Western Europe | 648,995 | 0.91% | |
| 28 | Turkey | Middle East & North Africa | 638,081 | 0.89% | |
| 29 | Netherlands | Western Europe | 635,082 | 0.89% | |
| 30 | Uzbekistan | Central Asia | 618,337 | 0.87% | |
| 31 | Kazakhstan | Central Asia | 617,300 | 0.86% | |
| 32 | Egypt | Middle East & North Africa | 615,235 | 0.86% | |
| 33 | Nepal | South Asia | 608,433 | 0.85% | |
| 34 | Iran | Middle East & North Africa | 601,064 | 0.84% | |
| 35 | Thailand | Southeast Asia | 574,187 | 0.80% | |
| 36 | Vietnam | Southeast Asia | 569,540 | 0.80% | |
| 37 | Guatemala | Latin America & Caribbean | 564,754 | 0.79% | |
| 38 | Romania | Central & Eastern Europe | 563,021 | 0.79% | |
| 39 | Peru | Latin America & Caribbean | 538,648 | 0.75% | |
| 40 | Philippines | Southeast Asia | 534,128 | 0.75% | |
| 41 | Cote d'Ivoire | Sub-Saharan Africa | 530,782 | 0.74% | |
| 42 | Sri Lanka | South Asia | 520,827 | 0.73% | |
| 43 | Ecuador | Latin America & Caribbean | 511,893 | 0.72% | |
| 44 | Pakistan | South Asia | 511,072 | 0.72% | |
| 45 | Sweden | Western Europe | 509,144 | 0.71% | |
| 46 | Cameroon | Sub-Saharan Africa | 508,380 | 0.71% | |
| 47 | South Africa | Sub-Saharan Africa | 494,301 | 0.69% | |
| 48 | Belgium | Western Europe | 480,252 | 0.67% | |
| 49 | Hungary | Central & Eastern Europe | 468,717 | 0.66% | |
| 50 | Austria | Western Europe | 463,887 | 0.65% | |
| 51 | Czechia | Central & Eastern Europe | 459,438 | 0.64% | |
| 52 | Portugal | Western Europe | 451,729 | 0.63% | |
| 53 | UAE | Middle East & North Africa | 450,778 | 0.63% | |
| 54 | Cuba | Latin America & Caribbean | 450,754 | 0.63% | |
| 55 | Switzerland | Western Europe | 450,438 | 0.63% | |
| 56 | Israel | Middle East & North Africa | 448,854 | 0.63% | |
| 57 | Greece | Western Europe | 448,035 | 0.63% | |
| 58 | Angola | Sub-Saharan Africa | 439,910 | 0.62% | |
| 59 | Zambia | Sub-Saharan Africa | 435,936 | 0.61% | |
| 60 | Iraq | Middle East & North Africa | 434,790 | 0.61% | |
| 61 | Azerbaijan | Central & Eastern Europe | 434,684 | 0.61% | |
| 62 | Ghana | Sub-Saharan Africa | 424,849 | 0.59% | |
| 63 | Senegal | Sub-Saharan Africa | 414,548 | 0.58% | |
| 64 | Dominican Republic | Latin America & Caribbean | 414,398 | 0.58% | |
| 65 | Belarus | Central & Eastern Europe | 408,723 | 0.57% | |
| 66 | Ethiopia | Sub-Saharan Africa | 406,923 | 0.57% | |
| 67 | Tanzania | Sub-Saharan Africa | 406,878 | 0.57% | |
| 68 | Zimbabwe | Sub-Saharan Africa | 405,038 | 0.57% | |
| 69 | Cambodia | Southeast Asia | 405,034 | 0.57% | |
| 70 | Myanmar | Southeast Asia | 396,263 | 0.55% | |
| 71 | Jordan | Middle East & North Africa | 394,819 | 0.55% | |
| 72 | DR Congo | Sub-Saharan Africa | 385,613 | 0.54% | |
| 73 | Bolivia | Latin America & Caribbean | 376,829 | 0.53% | |
| 74 | Tunisia | Middle East & North Africa | 373,123 | 0.52% | |
| 75 | Denmark | Western Europe | 363,617 | 0.51% | |
| 76 | Singapore | Southeast Asia | 358,029 | 0.50% | |
| 77 | Libya | Middle East & North Africa | 356,552 | 0.50% | |
| 78 | Benin | Sub-Saharan Africa | 353,916 | 0.50% | |
| 79 | Papua New Guinea | Oceania | 349,416 | 0.49% | |
| 80 | Ireland | Western Europe | 343,428 | 0.48% | |
| 81 | Bulgaria | Central & Eastern Europe | 343,127 | 0.48% | |
| 82 | Algeria | Middle East & North Africa | 341,006 | 0.48% | |
| 83 | Haiti | Latin America & Caribbean | 340,417 | 0.48% | |
| 84 | Norway | Western Europe | 339,769 | 0.48% | |
| 85 | Turkmenistan | Central Asia | 334,278 | 0.47% | |
| 86 | Venezuela | Latin America & Caribbean | 328,902 | 0.46% | |
| 87 | Finland | Western Europe | 328,700 | 0.46% | |
| 88 | Serbia | Central & Eastern Europe | 321,172 | 0.45% | |
| 89 | Kuwait | Middle East & North Africa | 317,473 | 0.44% | |
| 90 | Tajikistan | Central Asia | 316,429 | 0.44% | |
| 91 | Slovakia | Central & Eastern Europe | 313,040 | 0.44% | |
| 92 | Panama | Latin America & Caribbean | 308,934 | 0.43% | |
| 93 | Honduras | Latin America & Caribbean | 306,552 | 0.43% | |
| 94 | Mozambique | Sub-Saharan Africa | 303,478 | 0.42% | |
| 95 | Oman | Middle East & North Africa | 300,914 | 0.42% | |
| 96 | New Zealand | Oceania | 299,025 | 0.42% | |
| 97 | Paraguay | Latin America & Caribbean | 298,954 | 0.42% | |
| 98 | Croatia | Central & Eastern Europe | 296,543 | 0.42% | |
| 99 | Palestine | Middle East & North Africa | 294,673 | 0.41% | |
| 100 | Guinea | Sub-Saharan Africa | 279,613 | 0.39% | |
| 101 | Rwanda | Sub-Saharan Africa | 276,554 | 0.39% | |
| 102 | Madagascar | Sub-Saharan Africa | 272,164 | 0.38% | |
| 103 | Uruguay | Latin America & Caribbean | 268,807 | 0.38% | |
| 104 | Laos | Southeast Asia | 268,117 | 0.38% | |
| 105 | Costa Rica | Latin America & Caribbean | 262,208 | 0.37% | |
| 106 | El Salvador | Latin America & Caribbean | 259,908 | 0.36% | |
| 107 | Kyrgyzstan | Central Asia | 253,600 | 0.36% | |
| 108 | Niger | Sub-Saharan Africa | 252,896 | 0.35% | |
| 109 | Congo | Sub-Saharan Africa | 249,535 | 0.35% | |
| 110 | Georgia | Central & Eastern Europe | 241,007 | 0.34% | |
| 111 | Qatar | Middle East & North Africa | 239,824 | 0.34% | |
| 112 | Nicaragua | Latin America & Caribbean | 239,415 | 0.34% | |
| 113 | Yemen | Middle East & North Africa | 235,650 | 0.33% | |
| 114 | Uganda | Sub-Saharan Africa | 235,318 | 0.33% | |
| 115 | Afghanistan | South Asia | 233,242 | 0.33% | |
| 116 | Syria | Middle East & North Africa | 229,634 | 0.32% | |
| 117 | Lebanon | Middle East & North Africa | 228,372 | 0.32% | |
| 118 | Mongolia | East Asia | 228,166 | 0.32% | |
| 119 | Lithuania | Central & Eastern Europe | 220,628 | 0.31% | |
| 120 | Togo | Sub-Saharan Africa | 220,468 | 0.31% | |
| 121 | Bosnia and Herzegovina | Central & Eastern Europe | 216,719 | 0.30% | |
| 122 | Chad | Sub-Saharan Africa | 215,974 | 0.30% | |
| 123 | Mauritania | Sub-Saharan Africa | 214,809 | 0.30% | |
| 124 | Armenia | Central & Eastern Europe | 213,039 | 0.30% | |
| 125 | Moldova | Central & Eastern Europe | 211,524 | 0.30% | |
| 126 | Somalia | Sub-Saharan Africa | 205,371 | 0.29% | |
| 127 | Jamaica | Latin America & Caribbean | 201,950 | 0.28% | |
| 128 | Albania | Central & Eastern Europe | 198,459 | 0.28% | |
| 129 | Slovenia | Central & Eastern Europe | 197,875 | 0.28% | |
| 130 | Namibia | Sub-Saharan Africa | 183,841 | 0.26% | |
| 131 | Burundi | Sub-Saharan Africa | 181,899 | 0.25% | |
| 132 | Latvia | Central & Eastern Europe | 180,965 | 0.25% | |
| 133 | Bahrain | Middle East & North Africa | 178,279 | 0.25% | |
| 134 | Gabon | Sub-Saharan Africa | 176,653 | 0.25% | |
| 135 | Botswana | Sub-Saharan Africa | 174,978 | 0.25% | |
| 136 | Trinidad and Tobago | Latin America & Caribbean | 169,710 | 0.24% | |
| 137 | South Sudan | Sub-Saharan Africa | 168,839 | 0.24% | |
| 138 | Mali | Sub-Saharan Africa | 167,590 | 0.23% | |
| 139 | Malawi | Sub-Saharan Africa | 158,191 | 0.22% | |
| 140 | Burkina Faso | Sub-Saharan Africa | 157,582 | 0.22% | |
| 141 | Liberia | Sub-Saharan Africa | 156,609 | 0.22% | |
| 142 | North Macedonia | Central & Eastern Europe | 154,248 | 0.22% | |
| 143 | Cyprus | Western Europe | 154,221 | 0.22% | |
| 144 | Equatorial Guinea | Sub-Saharan Africa | 152,192 | 0.21% | |
| 145 | Estonia | Central & Eastern Europe | 152,062 | 0.21% | |
| 146 | Sudan | Sub-Saharan Africa | 144,675 | 0.20% | |
| 147 | Lesotho | Sub-Saharan Africa | 143,873 | 0.20% | |
| 148 | Sierra Leone | Sub-Saharan Africa | 130,843 | 0.18% | |
| 149 | Mauritius | Sub-Saharan Africa | 129,209 | 0.18% | |
| 150 | Eritrea | Sub-Saharan Africa | 119,473 | 0.17% | |
| 151 | Central African Republic | Sub-Saharan Africa | 110,133 | 0.15% | |
| 152 | Luxembourg | Western Europe | 109,785 | 0.15% | |
| 153 | Guyana | Latin America & Caribbean | 106,520 | 0.15% | |
| 154 | Fiji | Oceania | 104,734 | 0.15% | |
| 155 | Gambia | Sub-Saharan Africa | 102,966 | 0.14% | |
| 156 | Guinea-Bissau | Sub-Saharan Africa | 101,049 | 0.14% | |
| 157 | Timor-Leste | Southeast Asia | 100,698 | 0.14% | |
| 158 | Djibouti | Sub-Saharan Africa | 95,453 | 0.13% | |
| 159 | Eswatini | Sub-Saharan Africa | 92,637 | 0.13% | |
| 160 | Malta | Western Europe | 91,472 | 0.13% | |
| 161 | Montenegro | Central & Eastern Europe | 84,560 | 0.12% | |
| 162 | Iceland | Western Europe | 82,897 | 0.12% | |
| 163 | Brunei | Southeast Asia | 82,046 | 0.11% | |
| 164 | Bhutan | South Asia | 80,293 | 0.11% | |
| 165 | Suriname | Latin America & Caribbean | 79,896 | 0.11% | |
| 166 | Comoros | Sub-Saharan Africa | 78,732 | 0.11% | |
| 167 | Solomon Islands | Oceania | 76,734 | 0.11% | |
| 168 | Bahamas | Latin America & Caribbean | 73,958 | 0.10% | |
| 169 | Maldives | South Asia | 73,395 | 0.10% | |
| 170 | Belize | Latin America & Caribbean | 65,991 | 0.09% | |
| 171 | Barbados | Latin America & Caribbean | 64,740 | 0.09% | |
| 172 | Cabo Verde | Sub-Saharan Africa | 58,705 | 0.08% | |
| 173 | Vanuatu | Oceania | 49,036 | 0.07% | |
| 174 | Saint Lucia | Latin America & Caribbean | 45,751 | 0.06% | |
| 175 | Seychelles | Sub-Saharan Africa | 41,321 | 0.06% | |
| 176 | São Tomé and Príncipe | Sub-Saharan Africa | 40,742 | 0.06% | |
| 177 | Samoa | Oceania | 38,181 | 0.05% | |
| 178 | Grenada | Latin America & Caribbean | 35,255 | 0.05% | |
| 179 | Andorra | Western Europe | 34,331 | 0.05% | |
| 180 | Kiribati | Oceania | 31,022 | 0.04% | |
| 181 | Saint Vincent and the Grenadines | Latin America & Caribbean | 30,332 | 0.04% | |
| 182 | Tonga | Oceania | 30,258 | 0.04% | |
| 183 | Antigua and Barbuda | Latin America & Caribbean | 28,510 | 0.04% | |
| 184 | Micronesia | Oceania | 26,984 | 0.04% | |
| 185 | Saint Kitts and Nevis | Latin America & Caribbean | 24,872 | 0.03% | |
| 186 | Dominica | Latin America & Caribbean | 24,587 | 0.03% | |
| 187 | Liechtenstein | Western Europe | 23,352 | 0.03% | |
| 188 | Monaco | Western Europe | 21,252 | 0.03% | |
| 189 | Palau | Oceania | 19,918 | 0.03% | |
| 190 | San Marino | Western Europe | 19,885 | 0.03% | |
| 191 | Nauru | Oceania | 18,447 | 0.03% | |
| 192 | Marshall Islands | Oceania | 16,905 | 0.02% | |
| 193 | Tuvalu | Oceania | 16,480 | 0.02% |
Top 40 conditions by number of patient profiles
| # | Condition | Therapeutic area | Profiles |
|---|---|---|---|
| 1 | Dental caries | Oral & Dental | 1,124,174 |
| 2 | Tooth discoloration / whitening | Aesthetics & Cosmetic | 941,075 |
| 3 | Patent foramen ovale | Cardiovascular | 939,349 |
| 4 | Tension-type headache | Neurology | 934,817 |
| 5 | Helicobacter pylori infection | Infectious Disease | 885,097 |
| 6 | Fine lines & wrinkles | Aesthetics & Cosmetic | 861,516 |
| 7 | Periodontal disease | Oral & Dental | 814,883 |
| 8 | Vitamin D deficiency | Endocrinology & Metabolic | 772,646 |
| 9 | Photoaging / sun damage | Aesthetics & Cosmetic | 763,367 |
| 10 | Forehead / horizontal lines | Aesthetics & Cosmetic | 734,227 |
| 11 | Hypertension (essential) | Cardiovascular | 732,223 |
| 12 | Hyperlipidemia / dyslipidemia | Cardiovascular | 700,907 |
| 13 | Periorbital dark circles | Aesthetics & Cosmetic | 699,858 |
| 14 | Leg spider / reticular veins | Aesthetics & Cosmetic | 698,300 |
| 15 | Elevated lipoprotein(a) | Cardiovascular | 695,645 |
| 16 | Striae (stretch marks) | Aesthetics & Cosmetic | 693,471 |
| 17 | Nasolabial folds | Aesthetics & Cosmetic | 656,723 |
| 18 | Abdominal fat / contouring | Aesthetics & Cosmetic | 650,586 |
| 19 | Keratosis pilaris | Dermatology | 648,421 |
| 20 | Cellulite | Aesthetics & Cosmetic | 648,210 |
| 21 | Lateral canthal (crow's feet) lines | Aesthetics & Cosmetic | 639,413 |
| 22 | Glabellar (frown) lines | Aesthetics & Cosmetic | 626,904 |
| 23 | Enlarged pores | Aesthetics & Cosmetic | 619,825 |
| 24 | COVID-19 (high-risk) | Preventive & Vaccine-preventable | 605,051 |
| 25 | Skin texture / dullness | Aesthetics & Cosmetic | 589,356 |
| 26 | Herpes zoster (prevention indication) | Preventive & Vaccine-preventable | 569,003 |
| 27 | Presbyopia | Ophthalmology | 558,469 |
| 28 | Androgenetic alopecia (male pattern) | Aesthetics & Cosmetic | 558,294 |
| 29 | Obesity | Endocrinology & Metabolic | 557,593 |
| 30 | Myopia (progressive) | Ophthalmology | 554,769 |
| 31 | Astigmatism | Ophthalmology | 549,812 |
| 32 | Seasonal influenza (high-risk) | Preventive & Vaccine-preventable | 546,103 |
| 33 | RSV in older adults | Preventive & Vaccine-preventable | 545,180 |
| 34 | Pneumococcal disease (at-risk) | Preventive & Vaccine-preventable | 533,561 |
| 35 | Allergic rhinitis | Respiratory | 516,686 |
| 36 | Flank (love handle) fat | Aesthetics & Cosmetic | 513,927 |
| 37 | Tear trough / under-eye hollows | Aesthetics & Cosmetic | 512,732 |
| 38 | Seborrheic keratosis | Dermatology | 510,963 |
| 39 | Herpes simplex (HSV) | Infectious Disease | 495,730 |
| 40 | Varicose veins | Cardiovascular | 493,972 |
See all 731 conditions country by country in the patient panel explorer.
Definitions
- Patient profile
- One panel member profiled for one condition. A person living with two conditions is counted once for each, so profile totals are higher than the number of people.
- Therapeutic area
- A group of related conditions, such as oncology or cardiovascular.
About this data
Figures come from Global Vox Populi's proprietary panel coverage records and show panel membership as of October 2026. They describe the people available on the Global Vox Populi panel, not the total population of patient profiles in each country. Countries without current panel coverage are not listed. Totals across different Global Vox Populi panels should not be added together, because some people belong to more than one panel.
For live panel coverage and feasibility for a specific study, see the Patient panel explorer or use the survey feasibility calculator.
Frequently asked questions
How many patient profiles are on the Global Vox Populi panel?
71,411,997 patient profiles across 193 countries, as of October 2026.
Which country has the most patient profiles on the panel?
China (2,403,697), followed by Japan (1,974,800) and the United States (1,544,052).
How many patient profiles are on the panel in the United States?
1,544,052, ranking 3 of 193 countries (2.16% of the panel).
How many patient profiles are on the panel in the United Kingdom?
666,387, ranking 25 of 193 countries (0.93% of the panel).
How many patient profiles are on the panel in Germany?
669,787, ranking 23 of 193 countries (0.94% of the panel).
How many patient profiles are on the panel in Japan?
1,974,800, ranking 2 of 193 countries (2.77% of the panel).
How many patient profiles are on the panel in India?
1,354,449, ranking 4 of 193 countries (1.90% of the panel).
How many patient profiles are on the panel in Brazil?
1,054,165, ranking 10 of 193 countries (1.48% of the panel).
Why are there more patient profiles than people?
Each profile is one person with one condition. Someone living with diabetes and hypertension has two profiles, so profile totals count conditions, not individuals.
Can I use these statistics in my article or report?
Yes. Please credit "Global Vox Populi, Patient panel statistics, October 2026" and link to this page.
How often are these figures updated?
They are taken from Global Vox Populi's panel coverage records and refreshed periodically. The date at the top of the page shows when they were last updated.
Cite or link to this data
These statistics are free to use in articles, reports and presentations with a credit to Global Vox Populi and a link to this page.
Global Vox Populi (2026). Patient panel statistics 2026. October 2026. https://globalvoxpopuli.com/statistics/patient-panel-statistics/<a href="https://globalvoxpopuli.com/statistics/patient-panel-statistics/">Patient panel statistics 2026</a> (Global Vox Populi, October 2026)Run research with this audience
Global Vox Populi recruits from these proprietary panels for quantitative surveys, in-depth interviews and focus groups. ISO 9001, ISO 20252 and ISO/IEC 27001 certified and HIPAA compliant, following ESOMAR, Insights Association and BHBIA guidelines.
Request a feasibility check